Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann C Collier

Showing results (21-30 of 184) with videos related to

Pageof 19
Sort By:
AIDS (London, England)|August 14, 2018
Extended cell and plasma drug levels after one dose of a three-in-one nanosuspension containing lopinavir, efavirenz, and tenofovir in nonhuman primatesJosefin Koehn, Jennifer F Iwamoto, John C Kraft, et al.
AIDS (London, England)|May 5, 2017
Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimenHamza Coban, Kevin Robertson, Marlene Smurzynski, et al.
Biochemical Pharmacology|June 29, 2014
Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivoRüdiger Kaspera, Brian J Kirby, Tariku Sahele, et al.
AIDS Research and Human Retroviruses|October 11, 2008
HIV dynamics in seminal plasma during primary HIV infectionJoanne Stekler, Brian J Sycks, Sarah Holte, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 30, 2019
Screening and Enrollment by Sex in Human Immunodeficiency Virus Clinical Trials in the United StatesLaura M Smeaton, Deborah Kacanek, Kateryna Mykhalchenko, et al.
Nuclear Medicine and Biology|November 26, 2008
Rapid solid-phase extraction method to quantify [(11)C]-verapamil, and its [(11)C]-metabolites, in human and macaque plasmaJashvant D Unadkat, Francisco Chung, Lucy Sasongko, et al.
Clinical Pharmacology and Therapeutics|June 18, 2005
Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomographyLucy Sasongko, Jeanne M Link, Mark Muzi, et al.
The Journal of Infectious Diseases|March 27, 2012
CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studiesKatherine Tassiopoulos, Alan Landay, Ann C Collier, et al.
Nature Medicine|July 19, 2011
Protective HIV-specific CD8+ T cells evade Treg cell suppressionShokrollah Elahi, Warren L Dinges, Nicholas Lejarcegui, et al.
AIDS (London, England)|August 9, 2013
Factors associated with remaining on initial randomized efavirenz-containing regimensMarlene Smurzynski, Kunling Wu, Jeffrey T Schouten, et al.
Pageof 19

Showing results (21-30 of 184) with videos related to

Sort By:
Pageof 19
AIDS (London, England)|August 14, 2018
Extended cell and plasma drug levels after one dose of a three-in-one nanosuspension containing lopinavir, efavirenz, and tenofovir in nonhuman primatesJosefin Koehn, Jennifer F Iwamoto, John C Kraft, et al.
AIDS (London, England)|May 5, 2017
Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimenHamza Coban, Kevin Robertson, Marlene Smurzynski, et al.
Biochemical Pharmacology|June 29, 2014
Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivoRüdiger Kaspera, Brian J Kirby, Tariku Sahele, et al.
AIDS Research and Human Retroviruses|October 11, 2008
HIV dynamics in seminal plasma during primary HIV infectionJoanne Stekler, Brian J Sycks, Sarah Holte, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 30, 2019
Screening and Enrollment by Sex in Human Immunodeficiency Virus Clinical Trials in the United StatesLaura M Smeaton, Deborah Kacanek, Kateryna Mykhalchenko, et al.
Nuclear Medicine and Biology|November 26, 2008
Rapid solid-phase extraction method to quantify [(11)C]-verapamil, and its [(11)C]-metabolites, in human and macaque plasmaJashvant D Unadkat, Francisco Chung, Lucy Sasongko, et al.
Clinical Pharmacology and Therapeutics|June 18, 2005
Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomographyLucy Sasongko, Jeanne M Link, Mark Muzi, et al.
The Journal of Infectious Diseases|March 27, 2012
CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studiesKatherine Tassiopoulos, Alan Landay, Ann C Collier, et al.
Nature Medicine|July 19, 2011
Protective HIV-specific CD8+ T cells evade Treg cell suppressionShokrollah Elahi, Warren L Dinges, Nicholas Lejarcegui, et al.
AIDS (London, England)|August 9, 2013
Factors associated with remaining on initial randomized efavirenz-containing regimensMarlene Smurzynski, Kunling Wu, Jeffrey T Schouten, et al.
Pageof 19